These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6130778)

  • 21. Understanding and treating depression in anxious patients.
    Dubovsky SL
    J Clin Psychiatry; 1990 Oct; 51 Suppl():3-8; discussion 14-7. PubMed ID: 1976623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction: defining remission in patients treated with antidepressants.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348
    [No Abstract]   [Full Text] [Related]  

  • 23. Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
    Mielke DH; Gallant DM; McFarlain RA
    Curr Ther Res Clin Exp; 1976 May; 19(5):506-11. PubMed ID: 7433
    [No Abstract]   [Full Text] [Related]  

  • 24. Alprazolam in older depressed inpatients.
    Pitts WM; Fann WE; Sajadi C; Snyder S
    J Clin Psychiatry; 1983 Jun; 44(6):213-5. PubMed ID: 6133850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H
    Ann Pharm Fr; 2016 Mar; 74(2):93-118. PubMed ID: 26472602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do co-existing psychosocial problems influence the prescription of psychotropic medication in depressive and anxiety disorders?
    van Rijswijk E; Lucassen P; van De Lisdonk E; Zitman F; van Weel C
    Eur J Gen Pract; 2006; 12(1):37-9. PubMed ID: 16945871
    [No Abstract]   [Full Text] [Related]  

  • 28. Prescribing changes in anxiolytics and antidepressants in Slovenia.
    Svab V; Subelj M; Vidmar G
    Psychiatr Danub; 2011 Jun; 23(2):178-82. PubMed ID: 21685857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled comparative trial of clorazepate (Tranxene) and diazepam (Valium) for anxiety.
    Burrows GD; Dumovic P; Smith JA; Norman T; Maguire K
    Med J Aust; 1977 Oct; 2(16):525-8. PubMed ID: 23489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lateralized neuropsychological functioning in depressive patients before and after drug therapy.
    de Groot MH; Nolen WA; Huijsman AM; Bouvy PF
    Biol Psychiatry; 1996 Dec; 40(12):1282-7. PubMed ID: 8959293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study.
    Stein MB; Barrett-Connor E
    Am J Geriatr Psychiatry; 2002; 10(5):568-74. PubMed ID: 12213691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
    Sakkas P; Psarros C; Papadimitriou GN; Theleritis CG; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):960-2. PubMed ID: 16631291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep disorders in bipolar depression: hypnotics vs sedative antidepressants.
    Saiz-Ruiz J; Cebollada A; Ibañez A
    J Psychosom Res; 1994; 38 Suppl 1():55-60. PubMed ID: 7799252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antidepressive drugs - in anxiety, anxiolytics - in depression?].
    Drobizhev MY; Fedotova AV; Kikta SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11 Pt 2):74-8. PubMed ID: 24429969
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient acceptance as a factor in the effectiveness of treatment: an open assessment of potassium clorazepate ('Tranxene') and lorazepam in anxiety.
    Harris PG
    Curr Med Res Opin; 1974-1975; 2(10):664-8. PubMed ID: 4156290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary heart disease: treating the anxiety component.
    Wheatley D
    Prog Neuropsychopharmacol; 1980; 4(4-5):537-44. PubMed ID: 6111818
    [No Abstract]   [Full Text] [Related]  

  • 37. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 38. The anxiolytic SC 48274 (AGN 2979; BTG 1501) in generalized anxiety disorder.
    Gittos MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):i-ii. PubMed ID: 7863012
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics.
    Colman I; Croudace TJ; Wadsworth ME; Kuh D; Jones PB
    Br J Psychiatry; 2008 Oct; 193(4):327-31. PubMed ID: 18827297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression & anxiety in the primary care setting.
    Cunningham LA
    Compr Ther; 1997 Jun; 23(6):400-6. PubMed ID: 9239490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.